Literature DB >> 21320539

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.

Maria Paulke-Korinek1, Michael Kundi, Pamela Rendi-Wagner, Alfred de Martin, Gerald Eder, Birgit Schmidle-Loss, Andreas Vecsei, Herwig Kollaritsch.   

Abstract

Austria was the first country in Europe implementing a universal mass vaccination program against rotavirus gastroenteritis (RV-GE) for all infants nationwide. Epidemiological data from a hospital based surveillance system show that incidence rates of children hospitalized with RV-GE decreased in 2009 compared to 2008 and compared to the prevaccination period 2001-2005. Decreasing hospitalization-rates from RV-GE were observed in children of all age groups, even in those not eligible for vaccination according to their age, suggesting herd immunity induced by universal mass vaccination against RV-GE. In 2009 the disease burden was highest in children below three months of age stressing the importance of the early start of the immunization course.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320539     DOI: 10.1016/j.vaccine.2011.01.104

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

Review 1.  New insights into rotavirus vaccines.

Authors:  Chiara Mameli; Valentina Fabiano; Gian Vincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 2.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

Review 3.  Rotavirus vaccines: current status and future considerations.

Authors:  Catherine Yen; Jacqueline E Tate; Terri B Hyde; Margaret M Cortese; Benjamin A Lopman; Baoming Jiang; Roger I Glass; Umesh D Parashar
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

4.  Reply letter and clarifications on behalf of La Rosa and colleagues to Sicilian Public Health Authorities.

Authors:  Francesco La Rosa; Grasso Chiara; Valeria La Rosa; Valentina Taranto; Concetta Maria Spinello; Giuseppa La Camera; Marinella Astuto
Journal:  Hum Vaccin Immunother       Date:  2016-08-23       Impact factor: 3.452

5.  Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.

Authors:  V L Rahajamanana; J L Raboba; A Rakotozanany; N J Razafindraibe; E J P R Andriatahirintsoa; A C Razafindrakoto; S A Mioramalala; C Razaiarimanga; G G Weldegebriel; E Burnett; J M Mwenda; M Seheri; M J Mphahlele; A L Robinson
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

6.  Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.

Authors:  Sandra Dudareva-Vizule; Judith Koch; Matthias An der Heiden; Doris Oberle; Brigitte Keller-Stanislawski; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2012-09-07       Impact factor: 3.452

7.  Impact of rotavirus vaccine on premature infants.

Authors:  Jean-Michel Roué; Emmanuel Nowak; Grégoire Le Gal; Thomas Lemaitre; Emmanuel Oger; Elise Poulhazan; Jean-Dominique Giroux; Armelle Garenne; Arnaud Gagneur
Journal:  Clin Vaccine Immunol       Date:  2014-07-30

8.  Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.

Authors:  Francisco Giménez Sánchez; Esperanza Jiménez Nogueira; Miguel Sánchez Forte; Mercedes Ibáñez Alcalde; Elvira Cobo; Raquel Angulo; Pablo Garrido Fernández
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

Review 9.  A critical literature review of health economic evaluations of rotavirus vaccination.

Authors:  Samuel Aballéa; Aurélie Millier; Sibilia Quilici; Stuart Caroll; Stavros Petrou; Mondher Toumi
Journal:  Hum Vaccin Immunother       Date:  2013-04-09       Impact factor: 3.452

10.  Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova.

Authors:  Stela Gheorghita; Ludmila Birca; Ala Donos; Annemarie Wasley; Ion Birca; Radu Cojocaru; Anatol Melnick; Silviu Ciobanu; Liudmila Mosina; Margaret M Cortese; Umesh D Parashar; Ben Lopman
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.